173 related articles for article (PubMed ID: 28337379)
1. Long intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205.
Wang Y; Liu J; Bai H; Dang Y; Lv P; Wu S
Am J Cancer Res; 2017; 7(2):312-322. PubMed ID: 28337379
[TBL] [Abstract][Full Text] [Related]
2. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
[TBL] [Abstract][Full Text] [Related]
3. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.
Chen WM; Huang MD; Sun DP; Kong R; Xu TP; Xia R; Zhang EB; Shu YQ
Oncotarget; 2016 Mar; 7(9):9773-87. PubMed ID: 26799422
[TBL] [Abstract][Full Text] [Related]
4. LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495.
Lu Y; Liu WG; Lu JH; Liu ZJ; Li HB; Liu GJ; She HY; Li GY; Shi XH
Tumour Biol; 2017 May; 39(5):1010428317701632. PubMed ID: 28466784
[TBL] [Abstract][Full Text] [Related]
5. Long Non-coding RNA
Endo I; Amatya VJ; Kushitani K; Nakagiri T; Aoe K; Takeshima Y
Anticancer Res; 2023 Dec; 43(12):5367-5376. PubMed ID: 38030172
[TBL] [Abstract][Full Text] [Related]
6. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.
Ma P; Wang H; Sun J; Liu H; Zheng C; Zhou X; Lu Z
Cell Cycle; 2018; 17(8):974-984. PubMed ID: 29895195
[TBL] [Abstract][Full Text] [Related]
7. LINC00152 promotes pancreatic cancer cell proliferation, migration and invasion via targeting miR-150.
Yuan ZJ; Yu C; Hu XF; He Y; Chen P; Ouyang SX
Am J Transl Res; 2020; 12(5):2241-2256. PubMed ID: 32509216
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
Zhang L; Wang Y; Su H
Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression.
Li X; Rui B; Cao Y; Gong X; Li H
Oncol Lett; 2020 Mar; 19(3):2035-2042. PubMed ID: 32194700
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p.
Bian Z; Zhang J; Li M; Feng Y; Yao S; Song M; Qi X; Fei B; Yin Y; Hua D; Huang Z
Oncogenesis; 2017 Nov; 6(11):395. PubMed ID: 29180678
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
12. Long intergenic non‑protein coding RNA 152 promotes multiple myeloma progression by negatively regulating microRNA‑497.
Yu T; Xu Z; Zhang X; Men L; Nie H
Oncol Rep; 2018 Dec; 40(6):3763-3771. PubMed ID: 30272368
[TBL] [Abstract][Full Text] [Related]
13. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00152 is up-regulated in ovarian cancer tissues and regulates proliferation and cell cycle of SKOV3 cells.
Ni H; Niu LL; Tian SC; Jing LK; Zhang LT; Lin QQ; Cai YH; Liang HM; Du Q; Li H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9803-9813. PubMed ID: 31799647
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2.
Peng F; Shi X; Meng Y; Dong B; Xu G; Hou T; Shi Y; Liu T
Biomed Pharmacother; 2018 Sep; 105():1133-1140. PubMed ID: 30021349
[TBL] [Abstract][Full Text] [Related]
16. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.
Liu D; Gao M; Wu K; Zhu D; Yang Y; Zhao S
Biomed Pharmacother; 2019 Apr; 112():108654. PubMed ID: 30784933
[TBL] [Abstract][Full Text] [Related]
17. LINC00152 mediates CD8
Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis.
Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G
J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA LINC00152 Regulates Cell Proliferation, Migration And Invasion In Esophageal Squamous Cell Carcinoma Via miR-107/Rab10 Axis.
Zhou Z; Huang F
Onco Targets Ther; 2019; 12():8553-8567. PubMed ID: 31802892
[TBL] [Abstract][Full Text] [Related]
20. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma.
Yu J; Liu Y; Guo C; Zhang S; Gong Z; Tang Y; Yang L; He Y; Lian Y; Li X; Deng H; Liao Q; Li X; Li Y; Li G; Zeng Z; Xiong W; Yang X
J Cancer; 2017; 8(4):523-530. PubMed ID: 28367232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
